Open at the publisher →
In force since 2026-07-20, as the publisher states.
Copy read on 2026-11-10. The page it was read from
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.
sha256 166f4b1248b3148b0eac3ad1d4a21f30d388275cc10f7bef56daa33b2578de57
3 provisions
Title and introductory text
2026 No. 702
NATIONAL HEALTH SERVICE, ENGLAND
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026
Made
at 9.47 a.m. on 29th June 2026
Laid before Parliament
at 3.30 p.m. on 29th June 2026
Coming into force
20th July 2026
The Secretary of State for Health and Social Care makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006.
Propose a change1 Citation, commencement, extent and application
(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2026.
(2) These Regulations come into force on 20th July 2026.
(3) These Regulations extend to England and Wales and apply to England only.
Propose a change2 Amendment to regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (zero or nominal product reimbursement for vaccines and antivirals) is amended as follows.
(2) In paragraph (2)—
(a) omit “or” at the end of sub-paragraph (ae); and
(b) after sub-paragraph (ae), insert—
(af) a drug or medicine which is used for vaccinating or immunising people against meningococcal disease caused by—
(i) Neisseria meningitidis groups A, C, W and Y bacteria, or
(ii) Neisseria meningitidis group B bacteria,
if the conditions set out in paragraph (3) are satisfied;
(ag) a drug or medicine which is used for vaccinating or immunising people against tetanus, diphtheria and polio, if the conditions set out in paragraph (3) are satisfied; or
.
(3) In paragraph (3A), for “to (ae)” substitute “to (ag)”.
Propose a change